Next Quarterly Earnings
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Trevi Therapeutics is a US-based biopharmaceutical company specializing in the development of innovative therapies for chronic pruritus and neurological conditions. The company focuses on the development of Haduvio to provide essential treatment options for patients with significant unmet medical needs.
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Trevi Therapeutics is scheduled to report its next quarterly earnings on 11/11/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Trevi Therapeutics last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at -0.11 USD.
Trevi Therapeutics has beaten analyst EPS estimates in 3 of its last 5 evaluated quarters (beat rate: 60%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.